Comparison between Bethesda and thyroid imaging reporting and data system scoring in patients of thyroid swelling at a tertiary care hospital

Qazi N. Ahmed; Sayed Q.

doi:10.18203/2320-6012.ijrms20253165

Authors

Qazi N. Ahmed Department of General Surgery, Jamia Islamia Ishaatul Uloom’s Indian Institute of Medical Science and Research, Jalna, Maharashtra, India
Sayed Q. Department of General Surgery, Jamia Islamia Ishaatul Uloom’s Indian Institute of Medical Science and Research, Jalna, Maharashtra, India

DOI:

https://doi.org/10.18203/2320-6012.ijrms20253165

Keywords:

TIRADS, Bethesda, Thyroid swelling

Abstract

Background: Accurate diagnosis of thyroid swellings is crucial to differentiate benign from malignant lesions. The Bethesda system for reporting thyroid cytopathology (TBSRTC) and the thyroid imaging reporting and data system (TIRADS) are standardized tools used for cytological and ultrasonographic risk stratification, respectively. Objective was to compare the diagnostic performance of Bethesda and TIRADS scoring systems in evaluating thyroid nodules.

Methods: A prospective observational study was conducted over 18 months at a tertiary care hospital on 150 patients with thyroid swellings. All patients underwent ultrasound-based TIRADS scoring and FNAC using the Bethesda classification. The correlation of both scores with histopathological diagnosis was analyzed.

Results: Of 150 cases, 47 (31%) were malignant. TIRADS TR4-TR5 categories showed a strong correlation with Bethesda V-VI and histologically confirmed malignancies. Sensitivity, specificity, and diagnostic accuracy for TIRADS were 92.5%, 99.1%, and 97.3%, respectively. Combined TIRADS and Bethesda correlation further improved diagnostic confidence.

Conclusions: TIRADS scoring showed high concordance with Bethesda categories and histopathology. Combining both systems offers a robust preoperative risk stratification tool.

Metrics

Metrics Loading ...

References

Cibas ES, Ali SZ. The 2017 Bethesda system for reporting thyroid cytopathology. Thyroid. 2017;27(11):1341-6. DOI: https://doi.org/10.1089/thy.2017.0500

Kwak JY, Han KH, Yoon JH, Moon HJ, Son EJ, Park SH, et al. Thyroid imaging reporting and data system for US features of nodules: a step in establishing better stratification of cancer risk. Radiology. 2011;260(3):892-9. DOI: https://doi.org/10.1148/radiol.11110206

Tessler FN, Middleton WD, Grant EG, Hoang JK, Berland LL, Teefey SA, et al. ACR thyroid imaging, reporting and data system (TI-RADS): white paper of the ACR TI-RADS committee. J Am Coll Radiol. 2017;14(5):587-95.

Suh CH, Baek JH, Chung SR, Kim KW, Lee JH, Choi YJ. Diagnostic performance of thyroid imaging reporting and data system (TIRADS): a systematic review and meta-analysis. Eur Radiol. 2020;30(11):5611–24. DOI: https://doi.org/10.1007/s00330-020-06875-w

Grani G, Lamartina L, Ascoli V, Bosco D, Biffoni M, Giacomelli L, et al. Redesigning ultrasound risk stratification of thyroid nodules: a critical comparison of five systems. Head Neck. 2018;40(4):778-85.

Pandey P, Dixit A, Gautam A, Shukla VK. Prevalence of thyroid malignancy in nodular thyroid disease: a tertiary hospital experience. Indian J Surg Oncol. 2019;10(3):456-62.

Cabanillas ME, McFadden DG, Durante C. Thyroid cancer. Lancet. 2016;388(10061):2783-95. DOI: https://doi.org/10.1016/S0140-6736(16)30172-6

Russ G, Bonnema SJ, Erdogan MF, Durante C, Ngu R, Leenhardt L. European Thyroid Association Guidelines for TIRADS. Eur Thyroid J. 2017;6(5):225-37. DOI: https://doi.org/10.1159/000478927

Tessler FN, Middleton WD, Grant EG, Hoang JK, Berland LL, Teefey SA, et al. ACR TI-RADS: ultrasound risk stratification of thyroid nodules. Radiology. 2017;284(2):580-7. DOI: https://doi.org/10.1016/j.jacr.2017.01.046

Cibas ES, Ali SZ. The Bethesda System for Reporting Thyroid Cytopathology. Am J Clin Pathol. 2009;132(5):658-65. DOI: https://doi.org/10.1309/AJCPPHLWMI3JV4LA

Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid. 2016;26(1):1-33. DOI: https://doi.org/10.1089/thy.2015.0020

Yoon JH, Lee HS, Kim EK, Moon HJ, Kwak JY. Malignancy risk of thyroid nodules based on combined Bethesda and TI-RADS classification. Clin Endocrinol (Oxf). 2018;88(1):91-7.

Al Dawish M, et al. Predictive value of discordant TIRADS and Bethesda scores. Saudi Med J. 2020;41(2):173-80.

Zimmermann MB, Galetti V. Iodine intake as a risk factor for thyroid cancer: a comprehensive review. Endocr Rev. 2015;36(3):376-408.

Dean DS, Gharib H. Epidemiology of thyroid nodules. Best Pract Res Clin Endocrinol Metab. 2008;22(6):901-11. DOI: https://doi.org/10.1016/j.beem.2008.09.019

Sacks W, Yee J, Ohori NP, Richards ML, Lew JI. The role of standardized reporting systems in thyroid nodule management: review and future directions. J Am Coll Radiol. 2015;12(12 Pt B):1272–9.